Loading…

Kindeva Drug Delivery received a grant from the U.K. Government's Life Sciences Innovation Manufacturing Fund, unlocking a £33 million investment to enhance manufacturing capability and capacity for next-generation green pressurized metered-dose inhalers at its Loughborough and Clitheroe sites.
“This joint investment of public and private funds creates myriad new opportunities for Kindeva colleagues within the U.K.”businesswire.com
Summarized from public sources; check the original articles before acting on it.